{"count":2,"index":{"built_at":"2026-07-27T15:13:06.736921+00:00","public_records":55311,"revision":"7b85cebf7bbaa9fa4b838078"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Risks and limits of Menopause Basis"},"results":[{"answer":"The MyBody-X Menopause Basis test analyzes genetic variants linked to hormone metabolism and menopausal symptoms. However, the scientific basis is limited: most associations come from GWAS with small effect sizes, and clinical relevance is often unclear. The test cannot diagnose menopause or predict its onset. Only selected SNPs are examined, and their influence is overshadowed by environmental and lifestyle factors. Without accompanying blood tests (e.g., hormone levels), the interpretative value is low. MyBody-X itself states that results are not diagnostic. Users should discuss findings with a doctor, especially if experiencing symptoms like hot flashes or sleep disturbances. Evidence is mostly mechanistic and marketing-driven; independent clinical trials are lacking.","area":"gesundheit","canonical_id":"gesundheit:canonical-40f86cef457e44d857adfbbd","id":"public-c1615ac388c27bb3f36cce94","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Risks and limits of Menopause Basis","score":31.05220727,"snippet":"The MyBody-X Menopause Basis test analyzes genetic variants linked to hormone metabolism and menopausal symptoms. However, the scientific basis is limited: most associations come from GWAS with small effect sizes, and clinical relevance is often unclear. The test cannot diagnose menopause or predict its onset. Only selected SNPs are examined, and their influence is overshadowed by environmental and lifestyle factors. Without accompanying blood tests (e.g., hormone levels), the interpretative value is low. MyBody-X itself states that results are not diagnostic. Users should discuss findings with a doctor, especially if experiencing symptoms like hot flashes or sleep disturbances. Evidence is ","sources":[],"title":"Risks and limits of Menopause Basis","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c1615ac388c27bb3f36cce94/risks-and-limits-of-menopause-basis/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Genetic tests for menopause, as offered by direct-to-consumer (DTC) companies, often claim to predict the timing of menopause or the risk of early menopause. However, the scientific basis is weak. Genome-wide association studies (GWAS) have identified some variants (e.g., in MCM8, BRIP1) associated with age at natural menopause, but effect sizes are small. A polygenic risk score (PRS) from such variants has low predictive power – often explaining less than 10% of the variance. Clinical factors such as smoking, family history, chemotherapy, or ovarian surgery are far more relevant. Moreover, these tests are not diagnostic: they cannot confirm primary ovarian insufficiency (POI) or predict the exact age of menopause. The evidence comes mostly from population studies, not clinical validation. Risks include misinterpretation: a 'low genetic probability' may lead to false reassurance, while an 'elevated risk' can cause unnecessary anxiety. Most medical guidelines do not recommend genetic testing for menopause. Instead, women with symptoms or questions should seek gynecological advice. In summary, menopause genetic tests currently lack sufficient evidence – they may offer rough orientation but are not a reliable basis for health decisions.","area":"gesundheit","canonical_id":"gesundheit:canonical-f2213240e683a355969d3bf2","id":"public-a6a5db16772f349530dfe06c","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Risks and limits of Menopause Genetik","score":30.06684873,"snippet":"Genetic tests for menopause, as offered by direct-to-consumer (DTC) companies, often claim to predict the timing of menopause or the risk of early menopause. However, the scientific basis is weak. Genome-wide association studies (GWAS) have identified some variants (e.g., in MCM8, BRIP1) associated with age at natural menopause, but effect sizes are small. A polygenic risk score (PRS) from such variants has low predictive power – often explaining less than 10% of the variance. Clinical factors such as smoking, family history, chemotherapy, or ovarian surgery are far more relevant. Moreover, these tests are not diagnostic: they cannot confirm primary ovarian insufficiency (POI) or predict the","sources":[],"title":"Risks and limits of Menopause Genetik","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a6a5db16772f349530dfe06c/risks-and-limits-of-menopause-genetik/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}